Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 21.75
-1.20 (-5.23%)
Jan 21, 2026, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.54 billion as of January 21, 2026. Its market cap has decreased by -3.25% in one year.
Market Cap
3.54B
Enterprise Value
4.66B
Revenue
113.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.75
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.54B, a decrease of -11.51%. That is a compound annual growth rate of -1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.55B | 22.47% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 215.25B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.72B |
| Bora Pharmaceuticals Co., LTD. | 64.74B |
| Oneness Biotech | 33.97B |
| Center Laboratories | 31.09B |
| Lin BioScience | 30.77B |